Vor Biopharma Inc.

NASDAQ: VOR · Real-Time Price · USD
2.13
0.15 (7.58%)
At close: Aug 15, 2025, 3:59 PM
2.12
-0.24%
After-hours: Aug 15, 2025, 07:58 PM EDT

Vor Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-1.57B -32.49M -30.71M -27.56M -27.84M -30.8M -26.26M -33.19M -29.98M -28.43M -23.91M -23.79M -21.66M -22.74M -18.25M -18.55M -18.37M -13.72M
Depreciation & Amortization
2.04M 825K 865K 820K 869K 943K 892K -1.42M 3.19M 837K 632K 892K 575K 426K 395K 374K 354K 311K
Stock-Based Compensation
1.84M 1.93M 1.71M 2.26M 2.79M 3.08M 1.89M 3.16M 4.24M 4.07M 3.88M 3.33M 1.74M 1.75M 1.2M 1.15M 1.07M 891K
Other Working Capital
3.53M -1.26M -871K -584K 857K -1.64M -951K -1.39M 1.54M 88K -1.2M -1.8M -6.54M -2.6M -2.23M -1.11M -802K -3.01M
Other Non-Cash Items
1.53B 1.3M 1.26M 1.29M 922K 435K 3.73M -3.16M -4.24M 751K 2.25M 1.54M 1.65M 985K 893K 790K 1.19M 322K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -3.51M 5.45M 1.04M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
4.63M -2.64M 2.82M -99K 1.41M -4.12M -779K 1.27M 1.65M -1.49M -1.2M -874K -7.3M -3.32M -1.83M -1.11M -802K -5.45M
Operating Cash Flow
-35.18M -31.07M -24.06M -23.29M -21.85M -30.46M -24.03M -27.9M -24.1M -24.27M -18.35M -18.9M -24.99M -22.9M -17.59M -17.34M -16.57M -17.65M
Capital Expenditures
-152K -231K -72K -34K -9K -114K -111K -465K -399K -94K -321K -298K -5.83M -2.01M -1.17M -636K -919K -1.17M
Cash Acquisitions
799K n/a n/a n/a n/a n/a n/a -41K -14.04K -6.59K 96.72K n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a -1K -9.91M -16.55M 1K -34.96M -23.41M -118.14M n/a n/a -5.04M -4.79M -7.85M -75.12M n/a
Sales Maturities Of Investments
-1K 1K n/a n/a 53M 54M 27M 41M 49M 30M 21.43M 13M 3.13M n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a 41K 14.04K 6.59K -96.72K 13K 3.13K -5.04M -4.79M -7.85M -75.12M n/a
Investing Cash Flow
646K -230K -72K -34K 52.99M 43.97M 10.34M 40.54M 13.64M 6.5M -97.04M 12.7M -2.7M -7.05M -5.95M -8.49M -76.04M -1.17M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-32K n/a n/a n/a n/a n/a n/a n/a n/a -400K n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
175.06M -55K 53.7M -70K -51K -182K 40K -216K -361K -1.1M 631K 234K 100K 200K 308K 201K -445K -1.73M
Financial Cash Flow
175.06M -606K 53.29M 41K -31K 96K 25K 176K 218K 2.52M 112.26M 4.08M 604K 200K 307K 201K -445K 232.85M
Net Cash Flow
140.53M -31.9M 29.15M -23.28M 31.11M 13.6M -13.67M 12.81M -38.22M -15.25M -3.12M -2.13M -27.09M -29.76M -23.23M -25.63M -93.05M 214.03M
Free Cash Flow
-35.34M -31.3M -24.14M -23.32M -21.86M -30.58M -24.14M -28.36M -24.5M -24.36M -18.67M -19.2M -30.82M -24.91M -18.75M -17.98M -17.48M -18.82M